Randomized phase II study of gemcitabine and S-1 combination therapy versus S-1 in advanced biliary tract cancer. (JCOG 0805)
Phase of Trial: Phase II
Latest Information Update: 30 Apr 2014
At a glance
- Drugs Gemcitabine (Primary) ; Gimeracil/oteracil/tegafur
- Indications Biliary cancer; Gallbladder cancer
- Focus Therapeutic Use
- 09 Jul 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.
- 05 Jun 2012 Results presented at the 48th Annual Meeting of the American Society of Clinical Oncology.
- 21 Jan 2012 Results presented at the 2012 Gastrointestinal Cancers Symposium.